Neuro-Oncology

Published by: Oxford University Press  

People

  1. De Angelis
    De Angelis
  2. Panageas
    Panageas
  3. Pentsova
    Pentsova
  4. Souweidane
    Souweidane
  5. Young
    Young
  6. Boire
    Boire
  7. Haque
    Haque
  8. Humm
    Humm
  9. Kaley
    Kaley
  10. Pandit-Taskar
    Pandit-Taskar

Groups

  1. Tow Center for Developmental Oncology (TCDO) (20)
  2. GSK Faculty (16)
  3. Pediatrics, Department of (14)
  4. Radiology, Department of (13)
  5. Epidemiology and Biostatistics (12)
  6. Population Sciences Research Program (12)
  7. Survivorship Research (11)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (10)
  9. Human Oncology and Pathogenesis Program (10)
  10. Neuroradiology Service (10)
Search Within
  1. "2017"
Formats
  1. Meeting Abstract (47)
  2. Journal Article (16)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (20)
  2. GSK Faculty (16)
  3. Pediatrics, Department of (14)
  4. Radiology, Department of (13)
  5. Epidemiology and Biostatistics (12)
  6. Population Sciences Research Program (12)

More Groups

People
  1. Lisa De Angelis (11)
  2. Antonio Omuro (8)
  3. Katherine Panageas (7)
  4. Elena Pentsova (6)
  5. Mark Souweidane (6)
  6. Robert Young (6)

More People

Years
  1. 2017 (63)
Publishers
  1. Oxford University Press (63)

Results (63)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • PIK3 mutations are associated with decreased local control in brain metastases treated with radiation
    Meeting Abstract

    Lockney, N.; Wang, D.; Lin, A.; Pei, X.; Chan, T.; Yamada, Y.; Beal, K.; Yang, T. J.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: An NF Clinical Trials Consortium study
    Meeting Abstract

    Plotkin, S.; Tonsgard, J.; Ullrich, N.; Allen, J.; Blakeley, J.; Rosser, T.; Campian, J.; Clapp, W.; Fisher, M.; Cutter, G.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Single-agent dabrafenib for intracranial BRAF(V600E)-mutated histiocytosis
    Meeting Abstract

    Bhatia, A.; Ulaner, G.; Rampal, R.; Hyman, D.; Abdel-Wahab, O.; Durham, B.; Hajdenberg, J.; Ganzel, C.; Diamond, E.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Malignant transformation of neurocutaneous melanocytosis (NCM) following immunosuppression
    Meeting Abstract

    Schaff, L.; Marghoob, A.; Meyer, R.; Khakoo, Y.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Skin care products compatible with tumor treating fields
    Meeting Abstract

    Lacouture, M.; Hershkovich, H. S.; Blat, R.; Giladi, M.; Bomzon, Z.; Kirson, E. D.; Weinberg, U.; Palti, Y.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Tumor Treating Fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells: Implications for irradiation through TTFields transducer arrays
    Meeting Abstract

    Giladi, M.; Munster, M.; Schneiderman, R.; Voloshin, T.; Porat, Y.; Bomzon, Z.; Kirson, E. D.; Weinberg, U.; Palti, Y.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Value of T2-weighted MR imaging to evaluate drug distribution the brain stem of children
    Meeting Abstract

    Wembacher-Schroeder, E.; Zhou, Z.; Pandit-Tasker, N.; Souweidane, M. M.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • The development of neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: A single institution retrospective analysis
    Meeting Abstract

    Malani, R.; Haggiagi, A.; Holder, J.; Shames, Y.; Briggs, S.; Santomasso, B.; Callahan, M.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save

    • Neuro-Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 15235866 Unknown
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 The Author(s)
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Carden Jennings Publ Co Ltd
    Neuro-Oncology 1522-8517 Duke University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 Unknown
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 The Author(s) 2023
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 15235866 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Duke University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Society for Neuro Oncology